文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

外照射放疗与近距离放疗对根治性治疗的宫颈癌患者循环髓源性抑制细胞的影响

Effect of External Beam Radiation Therapy and Brachytherapy on Circulating Myeloid-Derived Suppressor Cell Populations in Patients Treated Definitively for Cervical Cancer.
PubMed 文献 · Adv Radiat Oncol · 2024-11-14

本研究纳入新诊断、未治疗的局部晚期宫颈癌患者,在标准顺铂放化疗前(T0)、外照射放疗后(T1)和近距离放疗后(T2)采集血样,用流式细胞术检测MDSC亚群。结果显示MDSC在放化疗后升高并于近距离放疗后达峰,其中粒细胞型MDSC较基线增加6.44倍,MDSC扩增与治疗反应无相关性。

要点

  • 循环MDSC在放化疗后升高,近距离放疗后达峰。
  • 粒细胞型MDSC亚群较基线增加6.44倍。
  • MDSC扩增与治疗反应无相关性。

核心结论

  • 宫颈癌患者循环MDSC在放化疗后升高,并与更晚期分期相关。
  • MDSC扩增由粒细胞型MDSC亚群驱动。
  • MDSC扩增与治疗反应无相关性,作者认为可能因本研究样本量有限。

研究设计与样本

  • 纳入新诊断、未治疗的局部晚期宫颈癌患者,按标准顺铂放化疗治疗。
  • 在放化疗前(T0)、外照射放疗后(T1)和近距离放疗后(T2)采集血样。
  • 用流式细胞术检测MDSC亚群,MDSC定义为Live/Dead-CD11b+CD33+HLA-DR-。

主要发现

  • 多数患者为白人非吸烟者,患人乳头瘤病毒相关宫颈鳞状细胞癌。
  • 治疗开始时更晚期疾病患者的MDSC频率呈升高趋势。
  • MDSC在放化疗后升高,并于近距离放疗后(T2)达峰。
  • 粒细胞型MDSC亚群较基线增加6.44倍。
  • MDSC扩增与治疗反应无相关性。

关键数值与推荐

  • MDSC亚群分为粒细胞型(CD15+CD14-)、单核细胞型(CD15-CD14+)和早期MDSC(CD15-CD14-)。

局限性

  • 作者认为MDSC扩增与治疗反应无相关性可能因本研究样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The immunosuppressive function of myeloid-derived suppressor cells (MDSCs) has been implicated in the regulation of immune responses against cancer and is associated with poor prognosis. Radiation treatment is known to alter immune cell populations within the tumor; however, whether this results in the recruitment of immunosuppressive MDSC populations is not well understood. Here we evaluate the response of circulating MDSC populations in patients treated per standard-of-care cisplatin chemoradiation therapy (CRT) for locally invasive cervical cancer. METHODS AND MATERIALS: Newly diagnosed, treatment-naïve patients with locally advanced cervical cancer were enrolled. Blood samples were collected from patients prior to starting CRT (T0), after external beam radiation therapy (T1), and after high-dose-rate brachytherapy (T2). Samples from each time point were processed, and the prevalence of MDSC subsets was determined using flow cytometry. MDSC populations were identified using Live/Dead-CD11b+CD33+HLA-DR- staining. MDSC subsets were further subdivided into granulocytic (g-, CD15+CD14-), monocytic (m-, CD15-CD14+), or early-MDSCs (e-, CD15-CD14-). RESULTS: Most patients in our study were Caucasian nonsmokers with human papillomavirus-associated squamous cell carcinoma of the cervix. We saw a trend for increased MDSC frequency in patients with more advanced-stage disease at the time of initiating treatment. MDSCs increase in response to CRT and peak after brachytherapy (T2). In particular, the g-MDSC subset increases by 6.44 times relative to the baseline. There was no correlation between MDSC expansion and response to therapy. CONCLUSION: Our study confirms other reports that circulating MDSCs in patients with cervical cancer increase in response to CRT and are associated with more advanced stages. Additionally, we show that MDSC expansion is driven by the g-MDSC subset. We did not see any correlation between MDSC expansion and treatment response, though this may be because of the limited sample size for this study.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Wanhainen KM, Berkseth M, Sando N, et al. Effect of External Beam Radiation Therapy and Brachytherapy on Circulating Myeloid-Derived Suppressor Cell Populations in Patients Treated Definitively for Cervical Cancer. Adv Radiat Oncol. 2024. PMID: 39703718. doi:10.1016/j.adro.2024.101677

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。